IL1B and Insulin resistance: Pro-inflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1β (IL-1β), disrupt insulin signaling, impair β-cell function, and exacerbate insulin resistance.